Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

Completed · Phase 3

Conditions studied: Anxiety Disorders

In brief

The primary objective of this study is to evaluate the efficacy of quetiapine SR compared to placebo in increasing time from randomisation to an anxiety event in patients with generalised anxiety disorder (GAD). PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Key facts

Study ID
NCT00314210
Run by
AstraZeneca
People needed
575
Starts
2006-03-01
Expected to finish
2007-08-01
Last updated by the study team
2009-03-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.